Keranova Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 34

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $4.33M

  • Investors
  • 6

Keranova General Information

Description

Developer of surgical instruments designed to supplant existing semi-manual, operator-dependent surgical procedures in ophthalmic surgery. The company's instruments allow an approach to offering anterior segment surgery reproducible through automated equipment possessing vision, intelligent software, and precise robotic movements, enabling doctors to substantially reduce manual intervention in favor of automation.

Contact Information

Website
www.keranova.fr
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 109 rue de la Montat
  • Le Ginkgo
  • 42000 Saint-Étienne
  • France
+33 04
Primary Industry
Surgical Devices
Vertical(s)
SaaS, TMT, HealthTech
Corporate Office
  • 109 rue de la Montat
  • Le Ginkgo
  • 42000 Saint-Étienne
  • France
+33 04

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Keranova Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 10-Oct-2023 $4.33M Completed Generating Revenue
2. Early Stage VC (Series B) 10-Sep-2019 Completed Generating Revenue
1. Early Stage VC (Series A) 11-Apr-2016 $5.64M $5.64M Completed Generating Revenue
To view Keranova’s complete valuation and funding history, request access »

Keranova Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
ADP B
Series B
Series A 62,857 $1.061853 $74.33 $74.33 1x $74.33 31.89%
To view Keranova’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Keranova Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of surgical instruments designed to supplant existing semi-manual, operator-dependent surgical procedures in o
Surgical Devices
Saint-Étienne, France
34 As of 2025

Eindhoven, Netherlands
 

Lake Forest, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Keranova Competitors (2)

One of Keranova’s 2 competitors is Preceyes, a Formerly VC-backed company based in Eindhoven, Netherlands.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Preceyes Formerly VC-backed Eindhoven, Netherlands
Altaviz Corporation Lake Forest, CA
You’re viewing 2 of 2 competitors. Get the full list »

Keranova Patents

  • 106

    Total Documents Applications and Grants

  • Total Patents Families

  • 84

    Granted

  • 15

    Pending

  • Expiring in next 12 mo

Keranova Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
FR-3142882-A1 System for cutting eye tissue into elementary portions Active 12-Dec-2022
FR-3142882-B1 System for cutting ocular tissue into elementary portions Active 12-Dec-2022
FR-3122570-A1 Coupling interface between a l.a.s.e.r. and a tissue to be treated Active 06-May-2021
CA-3218121-A1 Coupling interface between a laser source and a tissue to be treated Pending 06-May-2021
US-20240225898-A1 Coupling interface between a laser source and a tissue to be treated Pending 06-May-2021 A61F9/009
To view Keranova’s complete patent history, request access »

Keranova Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Keranova Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Financiere Arbevel PE-Backed Company Minority
Supernova Invest Venture Capital Minority
Tourrette Investissements PE/Buyout Minority
Bpifrance Sovereign Wealth Fund Minority
CEA Investissement Corporate Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

Keranova FAQs

  • When was Keranova founded?

    Keranova was founded in 2015.

  • Where is Keranova headquartered?

    Keranova is headquartered in Saint-Étienne, France.

  • What is the size of Keranova?

    Keranova has 34 total employees.

  • What industry is Keranova in?

    Keranova’s primary industry is Surgical Devices.

  • Is Keranova a private or public company?

    Keranova is a Private company.

  • What is the current valuation of Keranova?

    The current valuation of Keranova is .

  • What is Keranova’s current revenue?

    The current revenue for Keranova is .

  • How much funding has Keranova raised over time?

    Keranova has raised $36.6M.

  • Who are Keranova’s investors?

    Financiere Arbevel, Supernova Invest, Tourrette Investissements, Bpifrance, and CEA Investissement are 5 of 6 investors who have invested in Keranova.

  • Who are Keranova’s competitors?

    Preceyes and Altaviz are competitors of Keranova.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »